Citations 2
Feasibility and safety of outpatient hypomethylating agent and venetoclax initiation with and without ramp-up for newly diagnosed acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Shallis, Rory M. , Winer, Eric S. , Badar, Talha , Swaroop, Alok , Doukas, Peter H., Geramita, Emily , Agarwal, Sonal , Merl, Man Yee, Im, Annie , Litzow, Mark R. , Badar, Talha , Swaroop, Alok , Weiss, Julian J , Doukas, Peter, Le, Henry, Abaza, Yasmin , Podoltsev, Nikolai
Leukemia & Lymphoma | April 28, 2025 | Volume: 66 | Issue: 9 | Pages: 1735-1739
Feasibility and Safety of Outpatient Hypomethylating Agent (HMA) + Venetoclax (Ven) Initiation +/- Ramp-up for Patients (pts) with Newly-Diagnosed Acute Myeloid Leukemia (AML)
Shallis, Rory M. , Winer, Eric S. , Doukas, Peter H., Geramita, Emily , Agarwal, Sonal , Merl, Man Yee, Im, Annie , Litzow, Mark R. , Weiss, Julian J , Badar, Talha , Swaroop, Alok , Doukas, Peter, Le, Henry, Abaza, Yasmin , Podoltsev, Nikolai
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8921-8922